Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Status
Approved
Full Title
FELBATOL® (felbamate) Tablets 400 mg and 600 mg, Oral Suspension 600 mg/5 mL IN-00431-19/140907-0218 Rev. 2/2018 SOV-IN-00431-19/500489-02 Rev. 2/2018
United States
Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.